43rd Pharmacovigilance India 2026

Pharmacovigilance India 2026 is organized by Virtue Insight and will be held from Nov 18 - 19, 2026 at Kohinoor Continental, Mumbai, Maharashtra, India.

The 43rd Pharmacovigilance India 2026 brings together regulatory officials, pharmaceutical leaders, and drug safety experts to examine emerging trends in safety surveillance and compliance. As India’s life sciences market grows rapidly, this event focuses on modernizing systems to ensure drug safety across global healthcare channels. The agenda delivers strategic guidance for implementing technological, operational, and regulatory advancements.

This premier event brings together industry leaders, CROs, and regulatory experts to discuss key developments transforming drug safety. Key focus areas include AI-driven signal detection, automation, real-world evidence (RWE), risk management, and regulatory compliance. Designed for interactive discussion and peer-level networking, the conference offers essential insights into modernizing pharmacovigilance practices, optimizing outsourcing strategies, and strengthening patient safety standards across the global healthcare ecosystem

AI & Automation
Explore how artificial intelligence, machine learning, and automated literature screening are transforming signal detection and drug safety workflows. Discussions center on utilizing technology to transition toward continuous risk intelligence.

PV Outsourcing
Address strategic operational frameworks that effectively balance efficiency, high quality, and strict regulatory compliance. Panels evaluate India’s expanding role as a global hub for specialized pharmacovigilance services.

Risk Management
Reimagine risk management plans (RMPs) and risk evaluation frameworks to make sounder benefit-risk decisions. Sessions share actionable practices for maintaining safety throughout a drug’s lifecycle.

Real-World Evidence
Discover practical strategies for integrating Real-World Data (RWD) and Real-World Evidence (RWE) into safety monitoring systems. Experts demonstrate how observational data can enhance signal evaluation and patient outcomes.

Regulatory Harmonization
Examine evolving global compliance guidelines, combination product safety, and closer collaboration between industry and regulators. Speakers discuss frameworks that support innovative safety oversight.

Audit Readiness
Focus on vendor oversight, moving from effective CAPAs to a culture of compliance. Discussions outline predictive inspection strategies to address quality risks before formal findings occur.

Why Should You Attend
Networking
Curated Networking Opportunities Designed for Pharma and Biotech Professionals to Connect at a Meaningful, Peer Level
Session Formats
Discussion-driven Sessions in a Focused, Relaxed Environment-unlike Traditional Large-scale Exhibitors
Knowlwdge Sharing
Engage with senior industry leaders sharing strategic perspectives shaping the future of pharma and biotech

Who Should Attend & Who You’ll Meet:
Pharmacovigilance Strategy, Drug Safety/Risk Management, Information and Clinical Data Management, Clinical Research, Research & Development, Product Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data Analysis, Epidemiology project management, Regulatory Affairs and Compliance, Sales & Marketing, Biotech manufacturer.